CXCL10 and colitis: The expressions of ICAM-1, IL-1β, IL-16, CXCL10, MCP-1, CXCL9, CXCL12, and TIMP-1 were greatly reduced in MSC-EX-treated colitis group compared with those in the PBS-treated colitis group.